2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Monday, June 5, 2017

1:45pm-3:15pm: Safe Functional MR Imaging in STN-DBS implanted Parkinson’s disease

M. Saxena, C. McIntyre, B. Walter (Cleveland, OH, USA)

Surgical Therapy: Parkinson’s Disease · Exhibit Hall C

1:45pm-3:15pm: Safety and tolerability of deep brain stimulation in early stage Parkinson’s disease: Five-year follow-up of medication use and adverse events

A. Currie, M. Turchan, L. Heusinkveld, S. Millan, M. Hacker, A. Molinari, C. Gill, T. Davis, P. Konrad, F. Phibbs, P. Hedera, D. Charles (Memphis, TN, USA)

Surgical Therapy: Parkinson’s Disease · Exhibit Hall C

1:45pm-3:15pm: Safety of Unilateral and Bilateral DBS implants in ET: Preliminary results from Product Surveillance Registry

M. Schiess, S. Falowski, G. Plotkin, S. Palfi, T. Witt, E. Cuny, T. Theys, K. Martinez, R. Plunkett, Y. Temel, G. Johnson, T. Weaver, J. Krauss, P. Konrad (Houston, TX, USA)

Surgical Therapy: Other Movement Disorders · Exhibit Hall C

1:45pm-3:15pm: Safinamide improves both motor and non-motor symptoms in fluctuating Parkinson’s Disease patients.

C. Cattaneo (Bresso (Milan), Italy)

Parkinson's Disease: Non-Motor Symptoms · Exhibit Hall C

1:45pm-3:15pm: Saliva changes and the oral health in Parkinson´s disease

J. Tiigimäe-Saar, T. Tamme, P. Taba (Tartu, Estonia)

Parkinson's Disease: Non-Motor Symptoms · Exhibit Hall C

1:45pm-3:15pm: Secondary Vascular Parkinsonism in Uzbekistan: Hormonal Pathogenetic Effects and Vascular-Immunological Basics.

D. Akramova (Tashkent, Uzbekistan)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Exhibit Hall C

1:45pm-3:15pm: Self-rated burden grading of nonmotor symptoms identifies landmarks and subtypes of Parkinson’s disease: first report from a Moscow-Madrid-London collaboration

N. Titova, S. Cankaya, F. Spinnato, E. Katunina, P. Martinez-Martin, M. Qamar, K.R. Chaudhuri (Moscow, Russian Federation)

Parkinson's Disease: Non-Motor Symptoms · Exhibit Hall C

1:45pm-3:15pm: Semiquantitative analyses of DAT-SPECT imaging with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism

N. Morimoto, M. Takamiya, M. Morimoto (Takamatsu, Japan)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Exhibit Hall C

1:45pm-3:15pm: Serum cholesterol levels over time and risk of Parkinson’s disease

V. Rozani, T. Gurevich, N. Giladi, B. El-Ad, J. Tsamir, B. Hemo, C. Peretz (Tel A viv, Israel)

Epidemiology · Exhibit Hall C

1:45pm-3:15pm: Serum Mir-30c as a Potential Biomarker to Discriminate MSA from PD Patients: A Pilot Study.

A. Vallelunga, M. Sessa, D. Giovanna, M. Picillo, P. Barone, M.T. Pellecchia (Salerno, Italy)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Exhibit Hall C